Jiaping HE
7Patents
3h-index
16Co-inventors
46Inventor score
Filing activity: Dec 25, 2017 → May 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11363812B2 | Cell freezing medium for clinical use | Chemistry; Metallurgy | 4 | Active |
| US11066457B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 4 | Active |
| US11618778B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11608369B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11472858B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | Chemistry; Metallurgy | 3 | Active |
| US11339200B2 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | General | 0 | Revoked |
| US12356981B2 | Cell freezing medium for clinical use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.